Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
13 mai 2024 09h00 HE
|
Baylor Genetics
Baylor Genetics today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS).
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
02 oct. 2023 10h00 HE
|
Baylor Genetics
Baylor Genetics to present at three top genetic conferences on WES, WGS, carrier screening and non-invasive prenatal testing
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
12 sept. 2023 08h00 HE
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
Baylor Genetics Announces Epilepsy Panel
11 juil. 2023 10h01 HE
|
Baylor Genetics
HOUSTON, July 11, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, today announced the availability of an...
Baylor Genetics Announces Neuromuscular Disorders Panel
22 mai 2023 10h05 HE
|
Baylor Genetics
HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, today announced the availability of a...
Preimplantation Genetic Testing Market Value To Top Us$ 1.4 Billion By 2032 : Fact.MR Study
09 mars 2023 10h00 HE
|
FACT.MR
Rockville, March 09, 2023 (GLOBE NEWSWIRE) -- The global preimplantation genetic testing market is projected to grow at a staggering 9% value CAGR, reaching US$ 1,420 Million, following an...
Florida Cancer Specialists & Research Institute Chief Medical Officer Shares Spotlight with Global Innovators in Genomic Health
28 sept. 2022 10h00 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Lucio Gordan, MD, Chief Medical Officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, LLC (FCS), is a...
JScreen Honors February as National Cancer Prevention Month
15 févr. 2022 10h00 HE
|
JScreen
ATLANTA, Feb. 15, 2022 (GLOBE NEWSWIRE) -- JScreen, a national non-profit public health initiative dedicated to preventing genetic diseases, announces its participation in National Cancer Prevention...
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
02 nov. 2017 16h55 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017
27 avr. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...